Submitted by lec2010 on February 21, 2019 - 12:35pm
| Title | The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data. |
| Publication Type | Journal Article |
| Year of Publication | 2018 |
| Authors | Rutherford SC, Stewart EN, Chen Z, Chadburn A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L |
| Journal | Leuk Lymphoma |
| Volume | 59 |
| Issue | 1 |
| Pagination | 256-258 |
| Date Published | 2018 01 |
| ISSN | 1029-2403 |
| Keywords | Antiviral Agents, Eukaryotic Initiation Factor-4E, Humans, Lymphoma, Remission Induction, Respiratory Syncytial Virus Infections, Respiratory Syncytial Viruses, Retrospective Studies, Ribavirin |
| DOI | 10.1080/10428194.2017.1323270 |
| Alternate Journal | Leuk. Lymphoma |
| PubMed ID | 28573908 |